Status:
UNKNOWN
Comparison of the Effectiveness of Treatment With Mifepristone and Misoprostol at the Same Time Compared to the Administration of Drugs at a 48-hour Interval for Medical Abortion.
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Early Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Medical termination of pregnancy is a common and safe alternative to surgical termination of pregnancy(8). The current protocol in the investigators unit includes oral administration of Mifepristone 6...
Detailed Description
Medical termination of pregnancy is a common and safe alternative to surgical termination of pregnancy(8). According to the original protocol ,the administration of oral Mifepristone 600 mg is followe...
Eligibility Criteria
Inclusion
- intrauterine singleton pregnancy of less than 49 days, reassured by ultrasound examination
- patient who desire to terminate their pregnancy and have approval of the committee for termination of pregnancy
- patient who gave their consent to have a surgical abortion eventual if needed
Exclusion
- contraindication to Mifepristone or Misoprostol
- suspected ectopic pregnancy
- systemic treatment with steroids
- adrenal insufficiency
- heart and blood vessels disease
- coagulopathy or use of anti-thrombotic agents
- uncontrolled asthma
- liver or kidney insufficiency
- anorexia
- intrauterine device
- breastfeeding
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03440866
Start Date
March 1 2018
End Date
December 30 2023
Last Update
December 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HaEmek medical center
Afula, Israel